These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21640504)

  • 1. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors.
    Krstevska V; Stojkovski I; Zafirova-Ivanovska B
    Radiat Oncol; 2012 May; 7():78. PubMed ID: 22640662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma.
    Basu P; Jenson AB; Majhi T; Choudhury P; Mandal R; Banerjee D; Biswas J; Pan J; Rai SN; Ghim SJ; Miller D
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):102-110. PubMed ID: 26700705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.
    Espenel S; Garcia MA; Trone JC; Guillaume E; Harris A; Rehailia-Blanchard A; He MY; Ouni S; Vallard A; Rancoule C; Ben Mrad M; Chauleur C; De Laroche G; Guy JB; Moreno-Acosta P; Magné N
    Radiat Oncol; 2018 Feb; 13(1):16. PubMed ID: 29394940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Infection and Survival Among Women With Cervical Cancer.
    Dryden-Peterson S; Bvochora-Nsingo M; Suneja G; Efstathiou JA; Grover S; Chiyapo S; Ramogola-Masire D; Kebabonye-Pusoentsi M; Clayman R; Mapes AC; Tapela N; Asmelash A; Medhin H; Viswanathan AN; Russell AH; Lin LL; Kayembe MKA; Mmalane M; Randall TC; Chabner B; Lockman S
    J Clin Oncol; 2016 Nov; 34(31):3749-3757. PubMed ID: 27573661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
    Kang HB; Kim SH; Lee JH; Lee HC; Kang NK; Lee JH
    Int J Clin Oncol; 2024 May; 29(5):620-628. PubMed ID: 38530569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancer.
    Coutinho F; Gokhale M; Doran C; Monberg M; Yamada K; Chen L
    Cancer Treat Res Commun; 2024; 39():100800. PubMed ID: 38430610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.
    Hoskin P; Lee M; Dunkley D; Danh M; Wickens R; Saunders G; Northey J; Crabb S; McFarlane V; Sadozye A; Cooper R; Mathew T; Haslett K; Reeves K; Reed R; Bigos K; Williams KJ; Rowling E; Choudhury A; Dancer S; Smith D; Griffiths G
    BMC Cancer; 2024 Jun; 24(1):702. PubMed ID: 38849715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.
    Akyildiz A; Gultekin M; Yigit E; Demir E; Ismayilov R; Ahmed M; Buyukkor M; Yildirim HC; Yildirim N; Ucar G; Algin E; Ozturk AE; Akbas S; Selcukbiricik F; Orman S; Turan N; Yilmaz M; Colak R; Engin EO; Majidova N; Bayoglu IV; Beyaz H; Ates O; Ibıs K; Ergen SA; Yuce Sari S; Tezcan Y; Yildiz F; Arik Z
    Int J Gynecol Cancer; 2024 Jun; ():. PubMed ID: 38950923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K
    Dickie BR; Rose CJ; Kershaw LE; Withey SB; Carrington BM; Davidson SE; Hutchison G; West CML
    Br J Cancer; 2017 May; 116(11):1436-1443. PubMed ID: 28449009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
    Moore KN; Java JJ; Slaughter KN; Rose PG; Lanciano R; DiSilvestro PA; Thigpen JT; Lee YC; Tewari KS; Chino J; Seward SM; Miller DS; Salani R; Moore DH; Stehman FB
    Gynecol Oncol; 2016 Nov; 143(2):294-301. PubMed ID: 27542967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
    Grover S; Bvochora-Nsingo M; Yeager A; Chiyapo S; Bhatia R; MacDuffie E; Puri P; Balang D; Ratcliffe S; Narasimhamurthy M; Gwangwava E; Tsietso S; Kayembe MKA; Ramogola-Masire D; Dryden-Peterson S; Mahantshetty U; Viswanathan AN; Zetola NM; Lin LL
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):201-210. PubMed ID: 29619965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR).
    Buyukbayram ME; Hannarici Z; Turhan A; Caglar AA; Esdur PÇ; Bilici M; Tekin SB; Erdemci B
    BMC Cancer; 2024 May; 24(1):626. PubMed ID: 38783223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
    Charnalia M; Chopra S; Mulani J; Popat P; Rath S; Thomeer M; Mittal P; Gupta A; Boere I; Gupta S; Nout RA
    Int J Gynecol Cancer; 2024 Jun; 34(6):817-823. PubMed ID: 38649234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of tumor response in carcinoma of uterine cervix: data from tertiary cancer centre in India.
    Pathy S; Muwonge R; Chander S; Dadhwal V; Pandjatcharam J
    Bull Cancer; 2014 Feb; 101(2):E13-8. PubMed ID: 24590357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of patterns of care for women with cervical cancer in Morocco over a decade.
    Benider A; Bendahhou K; Sauvaget C; Mrabti H; Selmouni F; Muwonge R; Alaoui L; Lucas E; Chami Y; Abousselham L; Bennani M; Errihani H; Sankaranarayanan R; Bekkali R; Basu P
    BMC Cancer; 2022 May; 22(1):479. PubMed ID: 35501742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer.
    Buttarelli M; Babini G; Raspaglio G; Filippetti F; Battaglia A; Ciucci A; Ferrandina G; Petrillo M; Marino C; Mancuso M; Saran A; Villani ME; Desiderio A; D'Ambrosio C; Scaloni A; Scambia G; Gallo D
    J Exp Clin Cancer Res; 2019 Jun; 38(1):279. PubMed ID: 31242951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Serum Glucose in the Treatment of Locoregionally Advanced Pancreatic Cancer.
    Iarrobino NA; Gill BS; Klement RJ; Bernard ME; Champ CE
    Am J Clin Oncol; 2019 Sep; 42(9):692-697. PubMed ID: 31335348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer.
    Kunos CA; Fabian D; Fredericks T; Baldwin L; Dietrich C; Miller RW; Ueland FR
    Front Oncol; 2023; 13():1132135. PubMed ID: 37483504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PREDICTIVE POWER OF OXIDATIVE STRESS BIOMARKERS IN RECURRENCE AND SURVIVAL IN ADVANCED CERVICAL CANCER.
    Jelic M; Mandic A; Maricic S; Bozin B; Kladar N; Sudji J; Conic BS
    Exp Oncol; 2023 Oct; 45(2):231-241. PubMed ID: 37824768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.